What's in farzaneh hojjat's pipeline?

farzaneh hojjat has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with farzaneh hojjat's portfolio?

Top competitors by shared drug class: Actavis Inc., Bayer, Dr. August Wolff GmbH & Co. KG Arzneimittel, Hatice Tukenmez Kurnaz, Johns Hopkins University.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/farzaneh-hojjat.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

farzaneh hojjat — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

farzaneh hojjat pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
estradiol valerat	estradiol valerat	marketed	Estrogen receptor agonist	Estrogen receptor alpha (ERα), Estrogen receptor beta (ERβ)	Endocrinology

Therapeutic area mix

Endocrinology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Actavis Inc. · 1 shared drug class
Bayer · 1 shared drug class
Dr. August Wolff GmbH & Co. KG Arzneimittel · 1 shared drug class
Hatice Tukenmez Kurnaz · 1 shared drug class
Johns Hopkins University · 1 shared drug class
Martin Blomberg Jensen · 1 shared drug class
TriHealth Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for farzaneh hojjat:

Cite this brief

Drug Landscape (2026). farzaneh hojjat — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/farzaneh-hojjat. Accessed 2026-05-16.